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A total of 56 Staphylococcus aureus isolates incubated for 2 h in the presence or absence of oxacillin were
analyzed by flow cytometry after labeling with an S. aureus-specific peptide nucleic acid (PNA) probe. Two
defined ratios, the paired signal count ratio (PSCR) and the gate signal count ratio (GSCR), differentiated
methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) with sensitivities of 100%
each and specificities of 96% and 100%, respectively.
We have previously demonstrated that methicillin-resistant
Staphylococcus aureus (MRSA) and methicillin-susceptible S.
aureus (MSSA) isolates can be accurately and rapidly differ-
entiated by flow cytometry based on fluorescence intensity and
side scatter differences after brief exposure to oxacillin, using a
nonspecific fluorescent nucleic acid dye (5). Flow cytometry to
differentiate MRSA from MSSA would be even more useful if
the method could incorporate S. aureus-specific probe labeling
instead of using a nonspecific dye. S. aureus and other micro-
organisms can be accurately identified by labeling with specific
peptide nucleic acid-fluorescence in situ hybridization (PNA-
FISH) probes (3, 4).
Fresh overnight cultures of 56 clinical isolates of S. aureus
(28 MRSA, 28 MSSA) were prepared on Columbia blood agar.
These were isolates from blood, respiratory samples, tissue,
and wounds of patients with various infections. All isolates
came from separate patients. A 0.5 McFarland suspension in
saline was diluted 1/20 in cation-adjusted Mueller-Hinton
broth supplemented with 2% NaCl (CAMHB-NaCl) (1, 6).
One hundred microliters of this diluted suspension was added
to each of two tubes, one with 2 ml of CAMHB-NaCl contain-
ing 4 g/ml of oxacillin and the other with 2 ml of CAMHB-
NaCl without oxacillin, leaving an estimated inoculum size of
4  105 CFU/ml in the final suspensions. These two suspen-
sions were incubated at 37°C for 2 h.
After 2 h of incubation, 200 l was removed from each
suspension, placed in a 1.5-ml microcentrifuge tube, and incu-
bated for 3 min at 80°C. Then, 200 l of Cy5-labeled S. aureus-
specific PNA probe (AdvanDx, Woburn, MA) was added. Af-
ter incubating at 55°C for 30 min, the suspension was
centrifuged at 5,000  g for 5 min, the supernatant was re-
moved, and the pellet was resuspended in 500 l of wash
buffer. This was again incubated at 55°C for 10 min and cen-
trifuged at 5,000  g for 5 min; the supernatant was then
removed and the pellet again resuspended in 500 l of wash
buffer. This was again incubated at 55°C for 10 min. After
allowing 5 to 10 min for cooling, 400 l was removed and
added to 2.6 ml of phosphate buffer, to yield a final 3-ml
sample. This sample was analyzed in a MicroPRO flow cytom-
eter (Advanced Analytical Technologies, Inc., Ames, IA) using
a sampling volume of 0.25 ml, with cytometer settings as pre-
viously described (5).
Two analytic methods were evaluated to attempt to differ-
entiate MRSA from MSSA. The first method sought to differ-
entiate MRSA from MSSA based on differential growth rates
in the presence of oxacillin. Cell counts at 2 h were compared
for each isolate incubated in the presence or absence of oxa-
cillin, and a paired signal count ratio (PSCR) was defined for
each isolate as the ratio of signal event counts with and without
oxacillin exposure. The second method sought to differentiate
MRSA from MSSA based on differences in side scatter and
fluorescence intensity. Dot plots of side scatter versus fluores-
cence intensity were examined at 2 h for the isolates exposed to
oxacillin. Two gates were created and defined, with gate 1
containing most of the signal events corresponding to MSSA
and gate 2 containing most of those corresponding to MRSA.
A gate signal count ratio (GSCR) was then defined for each
isolate as the ratio of signal event counts in gate 2 to those in
gate 1. The PSCRs and GSCRs obtained were used to generate
receiver-operating characteristic (ROC) curves. The Sigma-
Plot 11.0 software (Systat Software Inc., San Jose, CA) was
used to generate the ROC curves and calculate the associated
areas, specificities, and sensitivities.
All 56 isolates were correctly identified as S. aureus by pro-
ducing a signal with the S. aureus-specific PNA probe utilized.
Additionally, MRSA and MSSA could be accurately differen-
tiated from each other in 2 h, based on differential PNA probe
uptake in the presence or absence of oxacillin (using the
PSCR) and on fluorescence intensity and side scatter differ-
ences on exposure to oxacillin (using the GSCR). Represen-
tative dot plots of side scatter versus fluorescence intensity for
MSSA and MRSA after 2 h of incubation in the presence or
absence of oxacillin are shown in Fig. 1. The ROC curve
describing the performance of the PSCR is shown in Fig. 2.
The area under the ROC curve was 0.9987 (95% confidence
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interval [CI], 0.9945 to 1.003) with a PSCR cutoff of 0.3725,
providing 100% sensitivity and 96% specificity. The GSCR
accurately differentiated MRSA from MSSA when the two
gates were defined as follows: for gate 1, fluorescence intensity,
2 to 8; side scatter, 5 to 50; for gate 2, fluorescence intensity, 5
to 50; side scatter, 50 to 200. The ROC curve for the perfor-
mance of the GSCR is outlined in Fig. 2. The area under the
ROC curve was 1.000, with a GSCR cutoff of 0.8263, providing
100% sensitivity and 100% specificity.
Our previous study showed that given a suspension of S.
aureus, one can differentiate MRSA from MSSA by flow cy-
tometry using a dye that stains nucleic acid in a nonspecific
manner (5). The present study shows that the same differen-
tiation can be achieved using an S. aureus-specific dye instead
of the nonspecific nucleic acid dye. This raises the possibility
that this method could selectively identify S. aureus within a
mix of microorganisms, thus making it possible to identify S.
aureus as well as differentiate MRSA from MSSA directly in
clinical samples, something that could not be done with non-
specific labeling of microorganisms. When considered in con-
junction with our previous study, one can conclude that incu-
bation in the presence of oxacillin rapidly (within 2 h) induces
changes in MRSA that allow differentiation from MSSA by
flow cytometry using fluorescence intensity and side scatter
readings using the defined GSCR. In this study, the ability to
differentiate within 2 h using the PSCR, which depends purely
on total signal counts, was an unexpected positive finding. Our
previous study demonstrated that viable cell counts are not
appreciably different at 2 h when MRSA and MSSA are incu-
bated in oxacillin-containing media, when assessed using non-
specific bacterial dye. Thus, the difference in the PSCR noted
in this study for MRSA and MSSA does not stem from a
difference in the number of viable microorganisms. Fewer sig-
nal events are detected with MSSA after 2 h than at baseline (0
h) when incubated in the presence of oxacillin; this result is
significantly different when the same comparison is made for
MRSA. The underlying mechanism for the difference in the
signal events is not clear. Nevertheless, the ability to differen-
tiate MRSA from MSSA with great accuracy in this study in a
reasonably sized cohort using methods similar to those in the
previous study suggests the diagnostic utility of this approach.
Using S. aureus-specific PNA probes, it has been previously
demonstrated that S. aureus can be identified rapidly and ac-
curately by flow cytometry in blood culture bottles growing
FIG. 1. Representative dot plots of MRSA and MSSA strains on flow cytometry after incubation in the presence or absence of oxacillin for 2 h,
with gate 1 (red) and gate 2 (blue) shown, highlighting differences in signal events.
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Gram-positive cocci (2). The ability to detect methicillin resis-
tance in addition to the presence of S. aureus would provide
additional clinically useful information in the same test. PNA
probes are currently being used in clinical microbiology labo-
ratories to rapidly identify S. aureus in blood culture bottles
found to be growing Gram-positive cocci in clusters. This study
demonstrates the potential to use flow cytometry to go one
step further and to rapidly determine methicillin susceptibility
in addition to identifying S. aureus. The method employed in
this assay requires multiple steps. Even with the multiple man-
ual steps involved, the total time to run a batch of 10 samples
was about 3.5 h, including the 2 h of incubation time. If this test
is considered one worthy of bringing to clinical use, many of
these steps are amenable to automation. The design of the flow
cytometer instrument we used and the nature of the test also
allow for random access testing, another advantage for an
assay under consideration for clinical application. The cost per
sample of the flow cytometry test using this method is esti-
mated to be about $24, compared with about $45 for the same
identification using a commercially available real-time PCR
assay. Rapid identification of S. aureus and differentiation of
MRSA and MSSA can be accomplished by real-time PCR also,
but the potential advantages of whole-cell analysis via flow
cytometry include simplified sample preparation, the ability for
random access testing, the potential for direct visual confirma-
tion of target cell morphology by fluorescence microscopy, and
the potentially lower cost per test.
This study was partially supported by Advanced Analytical Technol-
ogies, Inc., Ames, IA, and AdvanDx, Woburn, MA.
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FIG. 2. ROC curves for the paired signal count ratio (PSCR) and gated signal count ratio (GSCR) for differentiating MRSA from MSSA by
flow cytometry after 2 h of incubation in oxacillin-containing broth.
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